As the first 'systems biology' companies achieve some measure of success, the question remains whether systems biology can provide a viable business model. Karl Thiel investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cook, J. Biotech startup VLST gets $55 million. Seattle Post-Intelligencer, (June 16, 2006).
Lawrence, S. Bioentrepreneur, published online 22 December 2005 (doi:10.1038/bioent897).
Thiel, K. Nat. Biotechnol. 22, 1087–1092 (2004).
Hendrickson, D. Mass High Tech, published online Sept. 9, 2005 http://masshightech.bizjournals.com/masshightech/ stories/2005/09/12/story5.html
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Biologist aims to ease the pain for entrepreneurs
Can complexity be commercialized?
Web links
Rights and permissions
About this article
Cite this article
Thiel, K. Systems Biology, Incorporated?. Nat Biotechnol 24, 1055–1057 (2006). https://doi.org/10.1038/nbt0906-1055
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0906-1055
This article is cited by
-
Ins and Outs of Systems Biology vis-à-vis Molecular Biology: Continuation or Clear Cut?
Acta Biotheoretica (2010)
